Balstilimab: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Balstilimab

• A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
  NCT07227636 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
  NCT06782555 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer
  NCT06336902 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
  NCT06782932 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
  NCT06780787 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
  NCT06411691 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
  NCT07595874 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 11 locations
• Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
  NCT06300463 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)
  NCT05845450 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer
  NCT07735624 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation
  NCT06843551 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Balstilimab?

11 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.